Selpercatinib
규격
2152628-33-4CAS 번호
843-660-2EC 번호
6-(2-hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-3-pyridinyl]pyrazolo[1,5-a]pyridine-3-carbonitrileIUPAC 명칭
C29H31N7O3화학식
525.6 g/mol분자량
Selpercatinib; 2152628-33-4; Retevmo; 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile; CEGM9YBNGD; LY3527723; Ret inhibitor loxo-292; DTXSID901026442; WHO 10967; 6-(2-hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxypyridin-3-yl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyridin-3-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile; LY-3527723; 6-(2-hydroxy-2-methylpropoxy)-4-(6-{6-[(6-methoxypyridin-3-yl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl}pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile; 6-(2-Hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo(3.1.1)heptan-3-yl)pyridin-3-yl)pyrazolo(1,5-a)pyridine-3-carbonitrile; Pyrazolo(1,5-a)pyridine-3-carbonitrile, 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxy-3-pyridinyl)methyl)-3,6-diazabicyclo(3.1.1)hept-3-yl)-3-pyridinyl)-; selpercatinibum; RefChem:58689; RET Kinase Inhibitor LOXO-292; DTXCID001510634; 6-(2-Hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo(3.1.1)heptan-3-yl)pyridin-3-yl)pyrazolo(1,5-a)pyridine-3-carbonitril; 843-660-2; Loxo-292; LOXO292; 6-(2-Hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hept-3-yl]-3-pyridinyl]pyrazolo[1,5-a]pyridine-3-carbonitrile; US10112942, Example 166; Selpercatinib [INN]; Selpercatinib [USAN]; Serpercatinib; Retevmo (TN); MFCD31814089; UNII-CEGM9YBNGD; Selpercatinib (Standard); LOXO-292; Selpercatinib; Selpercatinib [USAN:INN]; Selpercatinib(LOXO-292); Selpercatinib (LOXO-292); Selpercatinib(LOXO-292)?; orb1299110; CHEMBL4559134; SCHEMBL20071478; SCHEMBL29349774; SCHEMBL29362388; Selpercatinib (JAN/USAN/INN); GTPL10318; CPD2206; BDBM296429; BDBM296432; GLXC-21357; GLXC-21860; HMS5086P13; EX-A2859; EBC-27276; NSC818434; s8781; ZB1574; US10112942, Example 163; US10112942, Example 183; AKOS037649115; HY-114370R; NSC-818434; AC-31588; BP-44049; BS-16622; DA-57785; Selpercatinib (LOXO-292, ARRY-192); example 163 [WO2018071447A1]; HY-114370; CS-0084279; T8222; D11713; D77980; EN300-27032767; 6-(2-hydroxy-2- methylpropoxy)-4-(6- (6-((5- methoxypyridin-2- yl)methyl)-3,6- diazabicyclo[3.1.1] heptan-3-yl)pyridin-3- yl)pyrazolo[1,5- a]pyridine-3- carbonitrile; 6-(2-hydroxy-2-methyl-propoxy)-4-[6-[6-[(6-methoxy-3-pyridyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-3-pyridyl]pyrazolo[1,5-a]pyridine-3-carbonitrile; 6-(2-hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-3-pyridinyl]pyrazolo[1,5-a]pyridine-3-carbonitrile; Selpercatinib; Pyrazolo[1,5-a]pyridine-3-carbonitrile, 6-(2-hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hept-3-yl]-3-pyridinyl]-; 6-(2-Hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hep동의어
Selpercatinib 함유 제품
레테브모정80밀리그램(셀퍼카티닙)레테브모정40밀리그램(셀퍼카티닙)레테브모캡슐40밀리그램(셀퍼카티닙)레테브모캡슐80밀리그램(셀퍼카티닙)RETSEVMO 80 MG CAPSULAS DURASRETSEVMO 40 MG CAPSULAS DURASRETSEVMO 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULARETSEVMO 80 mg CAPSULAS DURASRETSEVMO 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULARETSEVMO 40 mg CAPSULAS DURASRETSEVMO 80 mg, géluleRETSEVMO 80 mg, comprimé pelliculé
1/2 페이지
